Compare WVE & BANR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WVE | BANR |
|---|---|---|
| Founded | 2012 | 1890 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.2B |
| IPO Year | 2015 | 2015 |
| Metric | WVE | BANR |
|---|---|---|
| Price | $6.19 | $62.78 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 16 | 4 |
| Target Price | $29.81 | ★ $70.00 |
| AVG Volume (30 Days) | ★ 3.9M | 198.8K |
| Earning Date | 04-28-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.14% |
| EPS Growth | N/A | ★ 15.57 |
| EPS | N/A | ★ 1.60 |
| Revenue | ★ $3,704,000.00 | N/A |
| Revenue This Year | N/A | $0.73 |
| Revenue Next Year | $85.67 | $5.69 |
| P/E Ratio | ★ N/A | $40.60 |
| Revenue Growth | ★ 149.43 | N/A |
| 52 Week Low | $5.02 | $57.05 |
| 52 Week High | $21.73 | $69.83 |
| Indicator | WVE | BANR |
|---|---|---|
| Relative Strength Index (RSI) | 35.45 | 41.93 |
| Support Level | $6.02 | $61.64 |
| Resistance Level | $7.65 | $63.08 |
| Average True Range (ATR) | 0.35 | 1.24 |
| MACD | 0.05 | -0.13 |
| Stochastic Oscillator | 15.04 | 10.27 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho, and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.